Previous 10 | Next 10 |
Companhia Brasileira de Distribuicao (CBD) -76%.Soleno Therapeutics (SLNO) -26% after providing update on DCCR for the treatment of Prader-Willi syndromeSify Technologies (SIFY) -15%.Luokung Technology (LKCO) -15% after receipt of Nasdaq notification letter and a request for emergen...
Are These 5 Biotech Penny Stocks Worth Watching? With the extraordinary times we live in, Covid has resulted in a large investor focus on biotech penny stocks. Within the stock market, there’s no shortage of interesting biotech companies to choose from. In 2021, it’s best ...
DUBLIN, Ireland and CHICAGO, March 05, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both co...
DUBLIN, Ireland and CHICAGO, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both com...
UTILITY Therapeutics Joins Antimicrobials Working Group PR Newswire WASHINGTON , Feb. 17, 2021 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of UTILITY therapeutics Ltd. (UTILITY) to its coalition of companies with the missio...
After three missed endpoints in three pivotal trials, Iterum's antibiotic treatment Sulopenem displayed superiority over standard-of-care Cipro in uUTI patients with quinolone resistant pathogens. Iterum has submitted its NDA to the FDA, which has been accepted for priority review, wi...
DUBLIN, Ireland and CHICAGO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both com...
Can These 4 Penny Stocks Continue to Make Headway? So far, February has been kind to a variety of penny stocks . While this month has been quite volatile for the entire stock market, the sentiment seems to be quite bullish overall. Right now, several pieces of news could impact the ...
Iterum Therapeutics (ITRM) inks agreements with institutional investors for the purchase and sale of 17.5M ordinary shares at $2.00/share in a registered direct offering priced at-the-market.Expected gross proceeds are ~$35M. Net proceeds will be used for development and commercialization of ...
DUBLIN, Ireland and CHICAGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both com...
News, Short Squeeze, Breakout and More Instantly...
Iterum Therapeutics plc Company Name:
ITRM Stock Symbol:
NASDAQ Market:
Iterum Therapeutics plc Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
DUBLIN, Ireland and CHICAGO, June 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community...
DUBLIN and CHICAGO, June 05, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hosp...